In comparison to wild-type (WT) models, the expression levels of ISG15 and HMGCR were consistently upregulated in the KRAS/p53-driven mouse pancreatic cancer (KPC) models (Fig. 2B). This evidence concerns the gene TP53 and pancreatic neoplasm.